# A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

> **NCT02164084** · PHASE1 · COMPLETED · sponsor: **Novan, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** SB204
- **DRUG:** Vehicle Gel

## Key facts

- **NCT ID:** NCT02164084
- **Lead sponsor:** Novan, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02164084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02164084, "A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02164084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*